{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,10]],"date-time":"2024-08-10T15:13:31Z","timestamp":1723302811094},"reference-count":7,"publisher":"American Society of Consultant Pharmacists","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Consultant Pharmacist"],"published-print":{"date-parts":[[2014,4,1]]},"DOI":"10.4140\/tcp.n.2014.224","type":"journal-article","created":{"date-parts":[[2014,4,4]],"date-time":"2014-04-04T22:51:40Z","timestamp":1396651900000},"page":"224-238","source":"Crossref","is-referenced-by-count":6,"title":["2013 New Drug Update: What Do New Approvals Hold for the Elderly?"],"prefix":"10.4140","volume":"29","author":[{"given":"Daniel A.","family":"Hussar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2625","published-online":{"date-parts":[[2014,4,4]]},"reference":[{"key":"1","volume-title":"New Drugs (2008-2012) and Comparison Ratings, NDCR 2013 edition","author":"DA Hussar","year":"2013"},{"key":"2","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"CB Granger","year":"2011","journal-title":"N Engl J Med"},{"key":"3","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/dom.12054","article-title":"Efficacy and safety of canagliflozin monotherapy in subjects with type 2 diabetes mellitus inadequately controlled with diet and exercise","volume":"15","author":"K Stenlof","year":"2013","journal-title":"Diabetes Obes Metab"},{"key":"4","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1111\/j.1463-1326.2011.01463.x","article-title":"Alogliptin as a third oral antidiabetic drug in patients with type 2 diabetes and inadequate glycemic control on metformin and pioglitazone: a 52-week, randomized, double-blind, active-controlled, parallel-group study","volume":"13","author":"E Bosi","year":"2011","journal-title":"Diabetes Obes Metab"},{"key":"5","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1056\/NEJMoa0909809","article-title":"Multicenter, placebo-controlled trial of lorcaserin for weight management","volume":"363","author":"SR Smith","year":"2010","journal-title":"N Engl J Med"},{"key":"6","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1056\/NEJMoa1109071","article-title":"Placebo-controlled trial of tofacitinib monotherapy in rheumatoid arthritis","volume":"367","author":"R Fleischmann","year":"2012","journal-title":"N Engl J Med"},{"key":"7","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.rmed.2012.12.016","article-title":"Fluticasone furoate\/vilanterol (100\/25; 200\/25 mcg) improves lung function in COPD: a randomized trial","volume":"107","author":"FJ Martinez","year":"2013","journal-title":"Respir Med"}],"container-title":["The Consultant Pharmacist"],"original-title":[],"deposited":{"date-parts":[[2017,6,22]],"date-time":"2017-06-22T07:03:32Z","timestamp":1498115012000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.ingentaconnect.com\/content\/ascp\/tcp\/2014\/00000029\/00000004\/art00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,1]]},"references-count":7,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,4,1]]}},"alternative-id":["B4775J435T7M600L"],"URL":"https:\/\/doi.org\/10.4140\/tcp.n.2014.224","relation":{},"ISSN":["0888-5109"],"issn-type":[{"value":"0888-5109","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4,1]]}}}